Aging gonads, glands, and gametes:Â immutable or partially reversible changes?
Fertil. Steril., Nov (2012)
Role of decreased androgens in the ovarian response to stimulation in older women.
Fertil. Steril., Oct (2012)
Remarks from the editor.
Fertil. Steril., Mar;97(3):e11 (2012)
Can FSH co-trigger prevent OHSS?
Fertil. Steril., Mar;97(3):534-5 (2012)
Preventing severe OHSS has many different facets.
Fertil. Steril., Mar;97(3):536-8 (2012)
Lifestyle and metabolic approaches to maximizing erectile and vascular health.
Int. J. Impot. Res., 24(2):61-8 (2012 Mar-Apr)
The value of growth hormone supplements in ART for poor ovarian responders.
Fertil. Steril., Nov;96(5):1069-76 (2011)
The null hypothesis: closing the gap between good intentions and good studies.
Fertil. Steril., Jul;96(1):6-10.e2 (2011)
The link between erectile and cardiovascular health: the canary in the coal mine.
Am. J. Cardiol., Aug;108(4):599-606 (2011)
The WHO, WHY, WHAT, WHEN, WHERE, and HOW of clinical trial registries.
Fertil. Steril., Jul;96(1):2-5 (2011)
A multifaceted approach to maximize erectile function and vascular health.
Fertil. Steril., Dec;94(7):2514-20 (2010)
Microdose flare versus antagonist for poor responders.
Fertil. Steril., May;93(7):e35; author reply e36 (2010)
Adjuncts for ovarian stimulation: when do we adopt "orphan indications" for approved drugs?
Fertil. Steril., Jul;92(1):13-8 (2009)
Oral contraceptive pretreatment and half dose of ganirelix does not excessively suppress LH and may be an excellent choice for scheduling IUI cycles.
J. Assist. Reprod. Genet., Aug;25(8):417-20 (2008)
Oral contraceptive pretreatment in women undergoing controlled ovarian stimulation in ganirelix acetate cycles may, for a subset of patients, be associated with low serum luteinizing hormone levels, reduced ovarian response to gonadotropins, and early pre
Fertil. Steril., May;91(5):1963-5 (2009)
Patient preparation and standard stimulation regimens using gonadotropin-releasing hormone agonists.
Clin Obstet Gynecol., Mar;49(1):4-11 (2006)
Open electronic debate--even your obituary fails to escape peer review!
Fertil. Steril., Jul;82(1):260; author reply 260 (2004)
Is there a better match than yourself?
Fertil. Steril., Mar;81(3):725; author reply 725-6 (2004)
Assisted hatching reduces the age-related decline in IVF outcome in women younger than age 43 without increasing miscarriage or monozygotic twinning.
J. Assist. Reprod. Genet., Aug;15(7):418-21 (1998)
Success rate with repeated cycles of in vitro fertilization-embryo transfer.
Fertil. Steril., Jun;69(6):1005-9 (1998)
Pituitary function before, during, and after chronic gonadotropin-releasing hormone agonist therapy.
Fertil. Steril., Dec;58(6):1104-7 (1992)
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate.
Obstet Gynecol., Apr;75(4):641-5 (1990)
Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
J. Clin. Endocrinol. Metab., Jun;68(6):1111-7 (1989)
Factors influencing maintenance of sperm motility during in vitro processing.
Fertil. Steril., Nov;48(5):816-20 (1987)
Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval.
Fertil. Steril., Nov;48(5):807-10 (1987)
Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease.
J. Clin. Endocrinol. Metab., Oct;65(4):773-8 (1987)